Directed Arylation of 7‐Oxabicyclo[2.2.1]heptane to Prepare 3D Fragments
Open Access
- 15 July 2024
- journal article
- research article
- Published by Wiley in European Journal of Organic Chemistry
- Vol. 27 (35)
Abstract
Directed Pd‐catalysed β‐(hetero)arylation of the 7‐oxabicyclo[2.2.1]heptane framework is described. Arylated products were formed in up to 99 % yield, and heteroarylated products in up to 88 % yield with complete diastereoselectivity. Different minor diarylated side products were formed, depending on whether electron deficient aryl or pyridyl iodides were used as the coupling partners. Cleavage of the 8‐aminoquinoline directing group provided small bridged compounds that may be of value in fragment based drug discovery.Keywords
Funding Information
- University of Canterbury
- University of Canterbury (201118)
- Royal Society of Chemistry (R19-5035)
This publication has 44 references indexed in Scilit:
- A Guide to Directing Group Removal: 8‐AminoquinolineChemistry – A European Journal, 2021
- A Chemoselective α-Oxytriflation Enables the Direct Asymmetric Arylation of AmidesChem, 2019
- C−H Activation Enables a Concise Total Synthesis of Quinine and Analogues with Enhanced Antimalarial ActivityAngewandte Chemie International Edition, 2018
- Bridging C−H Activation: Mild and Versatile Cleavage of the 8‐Aminoquinoline Directing GroupChemistry – A European Journal, 2016
- Evaluating New Chemistry to Drive Molecular Discovery: Fit for Purpose?Angewandte Chemie International Edition, 2016
- C-H Bond Arylation of Diamondoids Catalyzed by Palladium(II) AcetateAdvanced Synthesis & Catalysis, 2016
- Palladium‐Catalyzed Directed C(sp3)–H Arylation of Saturated Heterocycles at C‐3 Using a Concise Optimization ApproachEuropean Journal of Organic Chemistry, 2015
- Opportunity Knocks: Organic Chemistry for Fragment‐Based Drug Discovery (FBDD)Angewandte Chemie International Edition, 2015
- Fragment-based hit identification: thinking in 3DDrug Discovery Today, 2013
- The impact of aromatic ring count on compound developability – are too many aromatic rings a liability in drug design?Drug Discovery Today, 2009